医療従事者の治療に必要な数値の解釈方法
Nicholas C Chesnaye1,2, Alberto Ortiz3, Merel van Diepen4
1ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, Netherlands.
まとめ
治療に必要な人数 (NNT) は介入の有効性を評価するのに役立ちます. NNT,Harm (NNH) に必要な数,およびHelpまたはHarm (LHH) を理解することは,臨床的決定に不可欠です.
科学分野:
- 医療 統計
- 臨床流行病学
- 証拠 に 基づく 医学
背景:
- 治療に必要な人数 (NNT) は,医療介入の有効性を評価する重要な指標です.
- 情報に基づいた臨床的意思決定は,治療効果の正確な解釈に依存しています.
研究 の 目的:
- バイナリとタイム・トゥ・イベントデータを用いてNNTの計算を解明する.
- 関連メトリクスを導入し定義する. 傷つけるために必要な数 (NNH) と助けられるか傷つけられる可能性 (LHH).
- 臨床研究におけるNNTの正しい適用と解釈に関するガイドラインを提供すること.
主な方法:
- バイナリーアウトカムのNNT計算の説明
- イベントまでの時間のデータに対するNNT計算の説明
- 共通の解釈の落とし穴とベストプラクティスの議論
主要な成果:
- 異なるデータ型でNNTを計算するための明確な方法論を提供します.
- NNTと共にNNHとLHHを定義し,文脈化しています.
- ベースラインリスク,時間,信頼区間を含むNNTの正確な解釈のための重要な要因を強調します.
結論:
- NNTの正確な計算と解釈は,エビデンスに基づいた医療実践に不可欠です.
- NNT,NNH,LHHの理解は,介入の有効性と患者の安全性の評価を強化します.
- NNTの適用に関するガイドラインに従うことは,信頼性の高い臨床意思決定を保証します.
関連する概念動画
01:13Therapeutic Index
5.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:12Hazard Ratio
243
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
243
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K
01:16Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
01:11Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153